Billion To One
BillionToOne - $BLLN - Their flagship prenatal test screens for genetic conditions like sickle cell and cystic fibrosis from a simple maternal blood draw, replacing invasive procedures like amniocentesis. The same platform now powers their oncology business, where liquid biopsy …